Anagnostics – Life Science “Microarray Technologie”

New platform technology for in-vitro diagnostics. The hybcell technology by Anagnostics is a decisive new development of microarray technology. The hybc delivers stable and reproducible results with easy handling and uncomplicated standardisation possibilities. Under these conditions, the way into in-vitro diagnostics is started.

Life Science Microarray Technology. The characteristic of microarrays is the miniaturisation of biochemical and molecular-biological methods. The microarray technology opens new dimensions with regard to sensitivity, throughput, parallelism, areas of application and cost reduction. 

Team: The masterminds behind Anagnostics are Dr. Bernhard Ronacher, a molecular geneticist and Mag. Christoph Reschreiter, computer scientist and Master of Business Management.

Dr. Bernhard Ronacher is a graduate molecular geneticist and doctor of biochemistry. Dr. Ronacher developed the first diagnostics bio-chip authorised for usage in Austria. Mag. Christoph Reschreiter graduated from the Technical College for Informatics/Electronics and then studied Commercial Science. For the leading Austrian automation supplier, Mr. Reschreiter established the Korean distribution subsidiary and recently led a software department with 25 employees.

Management Board
Mag. Christoph Reschreiter
Dr. Bernhard Ronacher

Contact
Anagnostics Bioanalysis GmbH
A-4020 Linz, Hafenstraße 47-51
Tel.: +43 (0)732 9015 6080
Fax: +43 (0)732 9015 6099
E-Mail: info@anagnostics.com

Website
www.anagnostics.com

 RSS Anagnostics: http://e-incubator.at/en/tag/anagnostics/feed